Erasca Inc. Common Stock vs National Beverage Corp. — how do they compare? Erasca Inc. Common Stock trades at $15.97 (market cap $5.40B), while National Beverage Corp. trades at $30.61 (market cap $2.89B). The key difference: Erasca Inc. Common Stock is the larger of the two by market cap, and Erasca Inc. Common Stock is trading nearer its 52-week high, National Beverage Corp. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Erasca Inc. Common Stock for 0 Days and National Beverage Corp. for 33 Days on average.
| ERAS | FIZZ | |
|---|---|---|
Market Cap | $5.40B | $2.89B |
Volume | 9,533,185 | 553,950 |
Sector | Health | Consumer Staples |
52-Week High | $22.47 | $37.73 |
52-Week Low | $2.20 | $29.20 |
Typical Hold Time | 0 Days | 33 Days |
Enterprise Value | $5.18B | $2.84B |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
National Beverage Corp. (FIZZ) trades at $30.52, up 3.11% today, showing mixed signals with a bullish technical outlook but bearish analyst sentiment. The company reported flat revenue of $1.2B in 2025 with net income of $186.82M, while recent quarterly earnings have missed expectations. Technical indicators show support at $30 and resistance at $31, with RSI in neutral territory. Recent news highlights margin pressure from tariffs and a $3.25 special dividend payment.
FIZZ faces headwinds from stalled revenue growth and margin compression, though strong profitability metrics (40.13% ROE) provide some support. Analyst consensus is cautious with 50% sell ratings, while institutional activity shows mixed positioning. The stock's valuation appears reasonable at 16.58 P/E, but investors should monitor earnings recovery and competitive pressures in the beverage sector.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Erasca is a biotechnology company developing precision medicines for cancer. Its programs target genetic drivers of tumor growth.
Read more on ERAS →National Beverage Corp is one of the top 10 non-alcoholic beverage companies in the U.S. Its portfolio skews toward functional drinks (that is those purporting to offer health benefits) and is anchored by the popular LaCroix sparkling water trademark. Other offerings include Rip It energy drinks, Everfresh juices, and soda brands like Shasta and Faygo. The firm controls most of its production and distribution apparatus, with very little outsourcing. In terms of go-to-market, it uses warehouse distribution for big-box retailers, direct-store-delivery for convenience stores and other small outlets, and food-service distributors for the food-service channel (schools, hospitals, restaurants). It is controlled by chairman and CEO Nick Caporella, who owns over 73% of the common stock.
Read more on FIZZ →